Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirabegron in Pulmonary Hypertension Secondary to Heart Failure
NCT02775539Phase 2Unknown
- Sponsor
- Centro Nacional de Investigaciones Cardiovasculares
- Start
- Jun 2016
- Primary completion
- Jan 2017
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of mirabegron in pulmonary hypertension (PH), sponsored by Centro Nacional de Investigaciones Cardiovasculares. Status: unknown.
02
Drugs
mirabegron
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT02775539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02775539.